The score is not available for this stock. This could be because (a) the market cap of the... Read More
Value score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
Price Momentum score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
QVM score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
526139-BOM Key Metrics
526139-BOM Share Price
Stock Analysis
Snapshot
Shareholding Pattern
Bulk, Block & Insider Trades
Corporate Actions
Company Profile
526139-BOM Share Price
526139-BOM
1 Week returns: -
1 Month returns: -
1 Year returns: -
3 Years CAGR: -
5 Years CAGR: -
Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
526139-BOM Stock Analysis
Views
Red Flags
Positive
Strong revenue growth and above median growth of industry
Company is net cash
Negative
Stock is fairly expensive with negative EPS on a trailing 12-month basis
Low and declining ROE
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Low operating margin but improving trend
Stock in GSM list
The stock has been places in Graded Surveillance Measure (GSM) list (GSM - 0).
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.0132167.
Snapshot
See detailed analysis
526139-BOM Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
526139-BOM Bulk, Block & Insider Trades
526139-BOM Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No dividend events found
Rights issue
Rights issue(3 new shares @ 20 INR for 5 existing shares) Ex-date: 13th Jan 1995 Announced on: 12th Jan 1995
Company Profile
Transgene Biotek Limited is an India-based biotechnology company. It is engaged in the research and development of vaccines, oncology, and new drug delivery technologies. Its portfolio of products includes oncology, autoimmunity, drug delivery and biogenetics. The Company offers TrabiAAV, which is a... Read More
Key personnel
Dr. K. Koteswara Rao
Managing Director
Shyam Shankar DasD
Director
Shri. Vikram PolavarapuD
Additional Director
Shri. Sarang Subhash PuranikD
Director
Dr. P. K. GhoshD
Independent Director
Shri. Soma Sekhar MarthiD
Independent Director
Smt. L. SujanaD
Independent Director
Shri. G. Santosh KumarD
Additional Non-Executive Independent Director
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Transgene Biotek Ltd.?
The current share price of Transgene Biotek Ltd. is ₹ 2.77 as of 09 Jan 2026.
What is the PE ratio of Transgene Biotek Ltd.?
The Price-to-Earnings (PE) ratio of Transgene Biotek Ltd. is - as of the latest financial data.
What is the ROE and ROCE of Transgene Biotek Ltd.?
Transgene Biotek Ltd. has a Return on Equity (ROE) of -42.98% and a Return on Capital Employed (ROCE) of -7.68% as per the latest financial reports.
What is the market cap of Transgene Biotek Ltd.?
The market capitalization of Transgene Biotek Ltd. stands at ₹ 20.99 Cr.
What is the dividend yield of Transgene Biotek Ltd.?
The dividend yield of Transgene Biotek Ltd. is 0.00% based on the current market price.
What is the RSI of Transgene Biotek Ltd.?
The Relative Strength Index (RSI) of Transgene Biotek Ltd. is 40.11.
What is the FII and DII holding in Transgene Biotek Ltd.?
Foreign Institutional Investors (FII) hold 0.00% and Domestic Institutional Investors (DII) hold 0.00% of Transgene Biotek Ltd. shares.
What sector does Transgene Biotek Ltd. belong to?
Transgene Biotek Ltd. operates in the Healthcare sector.
What is the beta of Transgene Biotek Ltd. stock?
The beta of Transgene Biotek Ltd. stock is 0.34, indicating its volatility relative to the broader market.
